Pharma Stocks
-
5,663 Contracts at Rs 1,100 Strike Price
Aurobindo Pharma Ltd. has become one of the most actively traded stocks, particularly in call options expiring on October 28,…
Read More » -
What’s Going On With Recursion Pharmaceuticals Stock On Wednesday? – Recursion Pharmaceuticals (NASDAQ:RXRX)
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at…
Read More » -
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025
Stock surges on AI buzz: Recursion Pharmaceuticals’ stock jumped roughly 16% on October 8, 2025 to around $6.08 [1], rebounding…
Read More » -
Nasus Pharma Expands Agreement with Aptar to Advance NS002
Nasus Pharma (NYSE: NSRX) announced on October 8, 2025 expanded agreements with…
Read More » -
Assessing Ascletis Pharma (SEHK:1672) Valuation After Substantial Share Price Surge
Ascletis Pharma (SEHK:1672) shares have been in focus lately, with investors watching for developments that might affect its outlook. Recent…
Read More » -
Recce Pharmaceuticals Completes Selective Buy-Back of Performance Shares
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert…
Read More » -
Explainer: PRIP can be the magic pill for drug discovery – Industry News
By Karishma Atul Shah and Hari Natarajan The Rs 5,000-crore Promotion of Research & Innovation in Pharma-MedTech (PRIP) scheme offers…
Read More » -
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket – Aehr Test System (NASDAQ:AEHR), Amkor Tech (NASDAQ:AMKR)
Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market trading after the company released promising preclinical study results for…
Read More » -
Cosmo Pharmaceuticals Receives MFDS Approval for Winlevi 1%
Cosmo Pharmaceuticals (OTC:CMOPF) announced that South Korea’s Ministry of Food and Drug…
Read More » -
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
Eagle Pharmaceuticals (OTCMKTS: EGRX) announced that its unaudited financial statements for the…
Read More »